Can SARS-CoV-2 be transmitted via faeces?

被引:16
作者
Moura, Ines B. [1 ]
Buckley, Anthony M. [1 ]
Wilcox, Mark H. [1 ,2 ]
机构
[1] Univ Leeds, Leeds Inst Med Res, Fac Med & Hlth, Healthcare Associated Infect Grp, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, Old Med Sch, Leeds Gen Infirm, Microbiol, Leeds, W Yorkshire, England
关键词
COVID-19; faecal transmission; gastrointestinal symptoms; gut microbiota; SARS-CoV-2; INFECTION; COVID-19;
D O I
10.1097/MOG.0000000000000794
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review COVID-19 patients can present gastrointestinal symptoms, being diarrhoea one of the most frequent, suggesting intestinal health can be impacted by COVID-19. Here, we will discuss whether there is a correlation between the presence of SARS-CoV-2 RNA in faeces and diarrhoea, the relevance of gastrointestinal symptoms in disease diagnosis and transmission, and how COVID-19 can impact the gut microbial balance. Recent findings SARS-CoV-2 RNA has been reported in faeces or rectal swabs of COVID-19 patients with and without diarrhoea, suggesting faecal shedding can occur independently of gastrointestinal symptoms. However, the presence of the virus in the intestine can persist beyond its presence in the respiratory tract, with some reports suggesting that SARS-CoV-2 in the faeces can be infectious. COVID-19 can impact the gut microbiota causing an enhancement of biosynthesis pathways that favour the expansion of bacterial pathogens in the inflamed gut, and causing a decline in commensals involved in the human immune response. Gastrointestinal symptoms may be the first indication of COVID-19. SARS-CoV-2 in faeces can potentiate routes of disease transmission, particularly as the high viral loads reported in patients with severe illness suggest virus replication in the intestine may be possible.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [41] Infection with SARS-CoV-2 can cause pancreatic impairment
    Deng, Wei
    Bao, Linlin
    Song, Zhiqi
    Zhang, Ling
    Yu, Pin
    Xu, Yanfeng
    Wang, Jue
    Zhao, Wenjie
    Zhang, Xiuqin
    Han, Yunlin
    Li, Yanhong
    Liu, Jiangning
    Lv, Qi
    Liang, Xujian
    Li, Fengdi
    Qi, Feifei
    Deng, Ran
    Wang, Siyuan
    Xiong, Yibai
    Xiao, Ruiping
    Wang, Hongyang
    Qin, Chuan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [42] Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
    Aleebrahim-Dehkordi, Elahe
    Soveyzi, Faezeh
    Deravi, Niloofar
    Rabbani, Zahra
    Saghazadeh, Amene
    Rezaei, Nima
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2021, 56 : 70 - 79
  • [43] The Pathogenicity of MERS-CoV, SARS-CoV and SARS-CoV-2: A Comparative Overview
    Shashank, Patil M.
    Prithvi, Shirahatti S.
    Ramith, Ramu
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (01): : 182 - 192
  • [44] Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE
    Lam, Su Datt
    Ashford, Paul
    Diaz-Sanchez, Sandra
    Villar, Margarita
    Gortazar, Christian
    de la Fuente, Jose
    Orengo, Christine
    VIRUSES-BASEL, 2021, 13 (04):
  • [46] Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
    Juric, Ivana
    Katalinic, Lea
    Furic-Cunko, Vesna
    Basic-Jukic, Nikolina
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (07) : 1775 - 1776
  • [47] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [48] SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan
    Nakagawa, So
    Katayama, Toshiaki
    Jin, Lihua
    Wu, Jiaqi
    Kryukov, Kirill
    Oyachi, Rise
    Takeuchi, Junko S.
    Fujisawa, Takatomo
    Asano, Satomi
    Komatsu, Momoka
    Onami, Jun-ichi
    Abe, Takashi
    Arita, Masanori
    GENES & GENETIC SYSTEMS, 2023, 98 (05) : 221 - 237
  • [49] Nachweismethoden von SARS-CoV-2 in GewebeMethods of SARS-CoV-2 detection in tissue
    Saskia von Stillfried
    Peter Boor
    Der Pathologe, 2021, 42 (2): : 208 - 215
  • [50] Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
    Ivana Juric
    Lea Katalinic
    Vesna Furic-Cunko
    Nikolina Basic-Jukic
    International Urology and Nephrology, 2022, 54 : 1775 - 1776